Different effects of complement depletion with Crry-Ig or anti-C5 antibody on collagen-induced arthritis in mice

被引：0
|
作者：
Banda, N
Kraus, D
Vondracek, A
Huynh, LH
Bendele, A
Holers, VM
Arend, WP
机构：
[1] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Denver, CO 80262 USA
[2] Univ Colorado, MCD Biol, Boulder, CO 80309 USA
来源：
FASEB JOURNAL | 2002年 / 16卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1217 / A1217
页数：1
相关论文
共 50 条
  • [1] Complement C3 inhibitor Crry-Ig leads to immune deviation without improvement in collagen induced arthritis (CIA) in mice
    Banda, NK
    Arend, WP
    Vondracek, A
    Cassidy, D
    Bendele, A
    Kraus, D
    Holers, VM
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S89 - S89
  • [2] Administration of an anti-C5 monoclonal antibody ameliorates established collagen-induced arthritis in mice and rats.
    Campagnuolo, G
    Kohno, H
    Caughey, DJ
    Hu, YL
    Middleton, S
    Bolon, B
    Feige, I
    Khare, SD
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S89 - S89
  • [3] Collagen-induced arthritis is inhibited in mice transgenic for the complement regulatory protein Crry
    Banda, NK
    Kraus, DM
    Muggli, M
    Bendele, AM
    Holers, VM
    Arend, WP
    FASEB JOURNAL, 2003, 17 (07): : C43 - C43
  • [4] Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor
    Quigg, RJ
    Kozono, Y
    Berthiaume, D
    Lim, A
    Salant, DJ
    Weinfeld, A
    Griffin, P
    Kremmer, E
    Holers, VM
    JOURNAL OF IMMUNOLOGY, 1998, 160 (09): : 4553 - 4560
  • [5] ANTI-C5 MONOCLONAL-ANTIBODY THERAPY PREVENTS COLLAGEN-INDUCED ARTHRITIS AND AMELIORATES ESTABLISHED DISEASE
    WANG, Y
    ROLLINS, SA
    MADRI, JA
    MATIS, LA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) : 8955 - 8959
  • [6] ANTI-C5 MONOCLONAL-ANTIBODY THERAPY PARENTS COLLAGEN-INDUCED ARTHRITIS AND AMELIORATES ESTABLISHED DISEASE
    WANG, Y
    ROLLINS, S
    MADRI, J
    MATIS, L
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1316 - 1316
  • [7] Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor.
    Holers, VM
    Kozono, Y
    Berthiaume, D
    Lim, A
    Salant, D
    Kremmer, E
    Ouigg, RJ
    FASEB JOURNAL, 1998, 12 (04): : A291 - A291
  • [8] COLLAGEN-INDUCED ARTHRITIS IN COMPLEMENT C5 DEFICIENT MICE
    BANERJEE, S
    ANDERSON, GD
    STUART, JM
    LUTHRA, HS
    DAVID, CS
    FASEB JOURNAL, 1988, 2 (06): : A1674 - A1674
  • [9] Amelioration of anti-phospholipid antibody (aPL) induced fetal loss in BALB/c mice using Crry-Ig, an inhibitor of complement component C3 activation.
    Salmon, JE
    Mo, L
    Guthridge, JM
    Molina, H
    Holers, VM
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S179 - S179
  • [10] Crry-Ig, a complement activation inhibitor, protects mice from ischemia/reperfusion (IR) induced intestinal injury
    Fleming, SD
    Rehrig, ST
    Guthridge, J
    Holers, VM
    Shea-Donohue, T
    Tsokos, G
    FASEB JOURNAL, 2000, 14 (06): : A1201 - A1201
12345